BioKangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Was Approved As Booster Dose in Indonesia


Published: Jan 11, 2022

On January 10, as reported by Indonesian National Agency of Drug and Food Control (BPOM), adenovirus vector COVID-19 vaccine (KCONECAVAC) manufactured by Shenzhen Kangtai Biological Products Co., Ltd. had been approved for emergency use authorization (EUA) of homologous booster dose.

View original source: